On this week’s Few & Far Between podcast episode, Biorasi’s CEO, Chris O'Brien, welcomes Karen Petrou and David Brint for an in-depth discussion on BioBonds and how they can jumpstart funding in clinical research for rare disease and other disorders.
"And what I was really surprised about was that everybody was doing data collection in a different way. And I kept thinking that, gosh,...
“I think one of the key insights and observations you make when you have a child who's sick and you spend time with other...
Why is the sharing of data so crucial to #raredisease research? Tune in for today's full episode of Few & Far Between. Episode 10...